Regeneron Pharmaceuticals Inc. sell Bank of America Co.
Start price
12.04.24
/
50%
€851.20
Target price
12.04.25
€676.58
Performance (%)
-41.86%
End price
13.04.25
€494.90
Summary
This prediction ended on 13.04.25 with a price of €494.90. The SELL prediction by Bank_of_America_Co_ for Regeneron Pharmaceuticals Inc. performed very well with a performance of -41.86%. Bank_of_America_Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Sell. Dividends of €0.84 are taken into consideration when calculating the performance. Bank_of_America_Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.060% | 0.060% | -2.072% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Bank of America Co. from $710.00 to $720.00. They now have an "underperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€480.80
17.04.25
17.04.25
€481.36
17.04.26
17.04.26
38.35%
27.02.26
27.02.26
Stopped prediction by Bank_of_America_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€678.20
07.01.26
07.01.26
€734.96
07.01.27
07.01.27
-2.31%
27.02.26
27.02.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€756.00
29.03.23
29.03.23
€599.43
29.03.24
29.03.24
19.37%
30.03.24
30.03.24